antidiabetic drug


Also found in: Dictionary, Thesaurus, Wikipedia.
Related to antidiabetic drug: acarbose

antidiabetic drug,

any of several drugs that control blood sugar level in the treatment of diabetesdiabetes
or diabetes mellitus
, chronic disorder of glucose (sugar) metabolism caused by inadequate production or use of insulin, a hormone produced in specialized cells (beta cells in the islets of Langerhans) in the pancreas that allows the body to use and store
..... Click the link for more information.
. See insulininsulin,
hormone secreted by the β cells of the islets of Langerhans, specific groups of cells in the pancreas. Insufficiency of insulin in the body results in diabetes. Insulin was one of the first products to be manufactured using genetic engineering.
..... Click the link for more information.
.
References in periodicals archive ?
Therefore it becomes quite important to evaluate the activities of antidiabetic drugs on changes in the concentration of sialic acid in diabetes mellitus.
A comprehensive analysis of the state of the art and key trends guides the reader through this emerging antidiabetic drug class.
The unique characteristic of weight reduction as well as the profound blood glucose lowering effect without significant hypoglycemia made GLP-1R agonists to a strongly emerging antidiabetic drug class.
Patients were matched based on diabetes duration, diabetes complications, cardiovascular complications, and previous antidiabetic drug use.
Macrovascular Outcomes: There have been no clinical studies establishing conclusive evidence of macrovascular risk reduction with ONGLYZA or any other antidiabetic drug.
com/research/5bf97k/research_report) has announced the addition of the "Concise Analysis of the Chinese Antidiabetic Drug Market" report to their offering.
The National Reimbursement Drug List was last updated in 2009, and several antidiabetic drug classes (e.
This report provides a comprehensive analysis of the blood glucose monitoring, insulin delivery and antidiabetic drug markets.
The purpose of this study was to address the lack of evidence of relative advantage of one antidiabetic drug class over the other with respect to risk of fracture as outlined in the Agency for Healthcare Research and Quality (AHRQ) 2011 comparative effectiveness review on oral medications for Type 2 Diabetes.
But it is the first oral, antidiabetic drug approved by the FDA since the agency issued guidance in December 2008 that required new agents of this type to undergo a more thorough evaluation of cardiovascular safety.
CRI estimates the CAGR of China antidiabetic drug market size will keep 15%.
The first pooled analysis using patient-level data from randomized clinical trials demonstrated that adding Lantus(R) (insulin glargine [rDNA] injection) to patients with type 2 diabetes, uncontrolled on oral antidiabetic drug therapy (OADs), was associated with a greater reduction in A1C levels and lower incidence of any hypoglycemia versus all comparators (OADs, NPH, lispro, premix).